Publication
Progressive Deafness-Dystonia due to SERAC1 Mutations: A Study of 67 cases
dc.contributor.author | Maas, RR | |
dc.contributor.author | Iwanicka-Pronicka, K | |
dc.contributor.author | Kalkan Ucar, S | |
dc.contributor.author | Alhaddad, B | |
dc.contributor.author | AlSayed, M | |
dc.contributor.author | Al-Owain, MA | |
dc.contributor.author | Al-Zaidan, HI | |
dc.contributor.author | Balasubramaniam, S | |
dc.contributor.author | Barić, I | |
dc.contributor.author | Bubshait, DK | |
dc.contributor.author | Burlina, A | |
dc.contributor.author | Christodoulou, J | |
dc.contributor.author | Chung, WK | |
dc.contributor.author | Colombo, R | |
dc.contributor.author | Darin, N | |
dc.contributor.author | Freisinger, P | |
dc.contributor.author | Garcia Silva, MT | |
dc.contributor.author | Grunewald, S | |
dc.contributor.author | Haack, TB | |
dc.contributor.author | van Hasselt, PM | |
dc.contributor.author | Hikmat, O | |
dc.contributor.author | Hörster, F | |
dc.contributor.author | Isohanni, P | |
dc.contributor.author | Ramzan, K | |
dc.contributor.author | Kovacs-Nagy, R | |
dc.contributor.author | Krumina, Z | |
dc.contributor.author | Martin-Hernandez, E | |
dc.contributor.author | Mayr, JA | |
dc.contributor.author | McClean, P | |
dc.contributor.author | De Meirleir, L | |
dc.contributor.author | Naess, K | |
dc.contributor.author | Ngu, LH | |
dc.contributor.author | Pajdowska, M | |
dc.contributor.author | Rahman, S | |
dc.contributor.author | Riordan, G | |
dc.contributor.author | Riley, L | |
dc.contributor.author | Roeben, B | |
dc.contributor.author | Rutsch, F | |
dc.contributor.author | Santer, R | |
dc.contributor.author | Schiff, M | |
dc.contributor.author | Seders, M | |
dc.contributor.author | Sequeira, S | |
dc.contributor.author | Sperl, W | |
dc.contributor.author | Staufner, C | |
dc.contributor.author | Synofzik, M | |
dc.contributor.author | Taylor, RW | |
dc.contributor.author | Trubicka, J | |
dc.contributor.author | Tsiakas, K | |
dc.contributor.author | Unal, O | |
dc.contributor.author | Wassmer, E | |
dc.contributor.author | Wedatilake, Y | |
dc.contributor.author | Wolff, T | |
dc.contributor.author | Prokisch, H | |
dc.contributor.author | Morava, E | |
dc.contributor.author | Pronicka, E | |
dc.contributor.author | Wevers, RA | |
dc.contributor.author | de Brouwer, AP | |
dc.contributor.author | Wortmann, SB | |
dc.date.accessioned | 2019-03-13T13:38:26Z | |
dc.date.available | 2019-03-13T13:38:26Z | |
dc.date.issued | 2017-12 | |
dc.description.abstract | OBJECTIVE: 3-Methylglutaconic aciduria, dystonia-deafness, hepatopathy, encephalopathy, Leigh-like syndrome (MEGDHEL) syndrome is caused by biallelic variants in SERAC1. METHODS: This multicenter study addressed the course of disease for each organ system. Metabolic, neuroradiological, and genetic findings are reported. RESULTS: Sixty-seven individuals (39 previously unreported) from 59 families were included (age range = 5 days-33.4 years, median age = 9 years). A total of 41 different SERAC1 variants were identified, including 20 that have not been reported before. With the exception of 2 families with a milder phenotype, all affected individuals showed a strikingly homogeneous phenotype and time course. Severe, reversible neonatal liver dysfunction and hypoglycemia were seen in >40% of all cases. Starting at a median age of 6 months, muscular hypotonia (91%) was seen, followed by progressive spasticity (82%, median onset = 15 months) and dystonia (82%, 18 months). The majority of affected individuals never learned to walk (68%). Seventy-nine percent suffered hearing loss, 58% never learned to speak, and nearly all had significant intellectual disability (88%). Magnetic resonance imaging features were accordingly homogenous, with bilateral basal ganglia involvement (98%); the characteristic "putaminal eye" was seen in 53%. The urinary marker 3-methylglutaconic aciduria was present in virtually all patients (98%). Supportive treatment focused on spasticity and drooling, and was effective in the individuals treated; hearing aids or cochlear implants did not improve communication skills. INTERPRETATION: MEGDHEL syndrome is a progressive deafness-dystonia syndrome with frequent and reversible neonatal liver involvement and a strikingly homogenous course of disease. Ann Neurol 2017;82:1004-1015 | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Ann Neurol. 2017 Dec;82(6):1004-1015 | pt_PT |
dc.identifier.doi | 10.1002/ana.25110 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/3195 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | John Wiley and Sons | pt_PT |
dc.subject | Adolescent | pt_PT |
dc.subject | Adult | pt_PT |
dc.subject | Amino Acid Sequence | pt_PT |
dc.subject | Carboxylic Ester Hydrolases | pt_PT |
dc.subject | Child | pt_PT |
dc.subject | Child, Preschool | pt_PT |
dc.subject | Cohort Studies | pt_PT |
dc.subject | Deaf-Blind Disorders | pt_PT |
dc.subject | Dystonia | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Infant | pt_PT |
dc.subject | Infant, Newborn | pt_PT |
dc.subject | Intellectual Disability | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Mutation | pt_PT |
dc.subject | Optic Atrophy | pt_PT |
dc.subject | Young Adult | pt_PT |
dc.subject | Disease Progression | pt_PT |
dc.subject | HDE MTB | pt_PT |
dc.title | Progressive Deafness-Dystonia due to SERAC1 Mutations: A Study of 67 cases | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 1015 | pt_PT |
oaire.citation.issue | 6 | pt_PT |
oaire.citation.startPage | 1004-1015 | pt_PT |
oaire.citation.volume | 82 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |